William Leland, MD
Gastroenterology · Greenville, NCNPI 1780664060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 30.9% of the total. Reporting peaked in 2021 at $705 and has fallen 63.7% since, to $256 in 2025.
Across 181 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$447
- Cook Medical LLC$220
- Pfizer$211
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$191
- Gilead$191
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,32998%
- Gifts$612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 55 | $1,048 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $447 |
| Cook Medical LLC | 9 | $220 |
| Pfizer | 14 | $211 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $191 |
| Gilead | 10 | $191 |
| Intercept Pharmaceuticals, Inc. | 10 | $175 |
| Merck | 11 | $162 |
| Ironwood Pharmaceuticals, Inc | 5 | $95 |
| Boston Scientific | 2 | $83 |
| Braintree Laboratories, Inc. | 4 | $79 |
| Johnson & Johnson | 5 | $78 |
| Ardelyx, Inc. | 2 | $61 |
| Pentax Of America, Inc. | 2 | $59 |
| Nestle Healthcare Nutrition Inc. | 2 | $42 |
| Redhill Biopharma Inc. | 2 | $40 |
| Bristol Myers Squibb | 2 | $32 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Sanofi | 1 | $24 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Intra-sana Laboratories | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
How this compares
$3,390 in reported general payments places this provider in the 60th percentile of 610 gastroenterology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colestipol Hcl | 25 | $2,272 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 46 | $792 |
| Esomeprazole Magnesium | 20 | $328 |
| Omeprazole | 35 | $254 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $174 |
| Gabapentin | 13 | $133 |
| Pantoprazole Sodium | 24 | $122 |
| Promethazine Hcl | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Greenville
- Nannaya JampalaGreenville$88K
- Phillip GoldsteinGreenville$19K
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Paul WatkinsChapel Hill$876K
- Nilesh LodhiaCharlotte$735K
- Evan DellonChapel Hill$431K
- Robert ReindollarSalisbury$430K
- Andrew StormWinston Salem$426K
- John PoulosFayetteville$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.